Assignee
SHANGHAI HUAYU BIOTECHNOLOGY CO LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2021–2021
Top patents by PatentIndex Score
3 records- 0159US2024009190A1Combination cancer therapy using chk inhibitorSHANGHAI HUAYU BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0252US2023201207A1Combination cancer therapy using n2-quinoline or isoquinoline substituted purine derivativesSHANGHAI HUAYU BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0350US2023087844A1Use of n2-quincline or isoquinoline substituted purine derivatives in cancer treatmentSHANGHAI HUAYU BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI HUAYU BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →